Dr. Bellman's HCG therapy claims need more context
Quick answer
HCG (human chorionic gonadotropin) is used in male hormone therapy as an LH analog to stimulate endogenous testosterone production and preserve spermatogenesis in men on exogenous testosterone. Common adjunct protocols range from 250-500 IU every other day to 500 IU twice weekly, while fertility-recovery protocols for men with TRT-induced azoospermia may use higher doses in the 1,000-3,000 IU range three times weekly under physician supervision. The 200,000 IU figure cited in this video has no basis in established clinical protocols and should not be interpreted as a dosing recommendation.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @socalurologyinstitute actually say?
The creator, who appears to be from a urology practice, answered a question about HCG dosing in the context of testosterone replacement therapy. They stated that HCG is dosed in International Units, not milligrams, and described "500 IU twice a week" as "the standard" for men co-administering HCG with TRT. They also mentioned higher doses, up to "a thousand IU's daily," for men with fertility concerns after long-term testosterone use. One figure in the video stands out immediately as a likely error: "200,000 IU's three times a week." That number is almost certainly a verbal slip, and it matters whether viewers catch it.
The core message is that HCG dosing is purpose-driven, varying based on whether the goal is testicular maintenance during TRT or active fertility recovery. That framing is reasonable clinical thinking.
Does the science back this up?
Mostly, yes, but with important nuance. The 500 IU twice-weekly protocol has legitimate support in the literature as a reasonable starting point for intratesticular testosterone preservation during exogenous testosterone use. The fertility-recovery doses are also grounded in clinical practice, though evidence is thinner.
Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) showed that 250 IU every other day was sufficient to maintain intratesticular testosterone in men on exogenous testosterone, suggesting lower doses may work for some patients. Lipshultz et al. (2010, Journal of Sexual Medicine) documented HCG use in hypogonadal men to preserve sperm production, supporting the logic of adjunct use. For azoospermia recovery in men who've been on TRT for years, higher doses in the 1,000-3,000 IU range three times weekly appear in fertility clinic protocols, which aligns with what the creator described, minus that 200,000 IU figure.
What did they get wrong (or right)?
The creator got the conceptual framework right: HCG works by mimicking LH, stimulating the Leydig cells in the testes to produce testosterone and support spermatogenesis. The dose-purpose relationship they described is clinically sound. Calling 500 IU twice a week "the standard" is defensible, though it is more accurately a commonly used starting protocol than a universal standard.
What they got wrong, almost certainly as a verbal mistake, is "200,000 IU's three times a week." No published protocol or clinical guideline supports this dose. Standard fertility-focused HCG doses top out around 1,500 to 3,000 IU three times a week in most protocols. A dose of 200,000 IU would carry serious risks of overstimulation and is not used in male hormone therapy contexts. If a patient heard that number and ran with it, that is a real problem. The cost comment is accurate: HCG and its analog chorionic gonadotropin are expensive, and the 2020 FDA ban on compounded HCG created additional access barriers that patients legitimately face.
What should you actually know?
HCG is a legitimate clinical tool with a real evidence base. For men on TRT who want to preserve testicular function or maintain some fertility potential, co-administration is a reasonable strategy, and this video conveys that correctly. The dose range matters, and the purpose-driven framing the creator uses is how most urologists and reproductive endocrinologists actually approach it.
What this video cannot tell you is whether HCG is right for your situation, what dose is appropriate for you, or how your response will differ based on how long you have been on testosterone, your baseline LH sensitivity, or your fertility goals. Coviello et al. found meaningful individual variation in intratesticular testosterone response even at consistent doses. A single TikTok, even from a credentialed urology practice, cannot account for that. Talk to a physician who can order the right labs and monitor your response. The 200,000 IU figure should be treated as a misstatement, not a clinical recommendation.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Dr. Bellman's HCG therapy claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Dr. Bellman's HCG therapy claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
HCG (human chorionic gonadotropin) is used in male hormone therapy as an LH analog to stimulate endogenous testosterone production and preserve spermatogenesis in men on exogenous testosterone.
FormBlends verdict
HCG (human chorionic gonadotropin) is used in male hormone therapy as an LH analog to stimulate endogenous testosterone production and preserve spermatogenesis in men on exogenous testosterone. Common adjunct protocols range from 250-500 IU every other day to 500 IU twice weekly, while fertility-recovery protocols for men with TRT-induced azoospermia may use higher doses in the 1,000-3,000 IU range three times weekly under physician supervision. The 200,000 IU figure cited in this video has no basis in established clinical protocols and should not be interpreted as a dosing recommendation.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- HCG (human chorionic gonadotropin) is used in male hormone therapy as an LH analog to stimulate endogenous testosterone production and preserve spermatogenesis in men on exogenous testosterone. Common adjunct protocols range from 250-500 IU every other day to 500 IU twice weekly, while fertility-recovery protocols for men with TRT-induced azoospermia may use higher doses in the 1,000-3,000 IU range three times weekly under physician supervision. The 200,000 IU figure cited in this video has no basis in established clinical protocols and should not be interpreted as a dosing recommendation.
- 500 IU twice weekly is a commonly used HCG adjunct protocol during TRT, but Coviello et al. (2005, JCEM) showed 250 IU every other day may be sufficient for intratesticular testosterone preservation in some men.
- HCG works by mimicking LH to stimulate Leydig cells, which is why it can partially offset the testicular suppression caused by exogenous testosterone.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- 500 IU twice weekly is a commonly used HCG adjunct protocol during TRT, but Coviello et al. (2005, JCEM) showed 250 IU every other day may be sufficient for intratesticular testosterone preservation in some men.
- HCG works by mimicking LH to stimulate Leydig cells, which is why it can partially offset the testicular suppression caused by exogenous testosterone.
- The 200,000 IU figure stated in this video has no support in clinical literature or guidelines and should be treated as a verbal mistake, not a dosing reference.
- Fertility-recovery protocols after long-term TRT typically use doses in the 1,000-3,000 IU range three times weekly, often combined with other agents like clomiphene, under specialist supervision.
- The 2020 FDA reclassification of HCG as a biologic effectively ended most compounded HCG access, making cost a genuine and documented barrier to this treatment.
- Individual response to HCG varies significantly based on duration of prior TRT use, baseline Leydig cell function, and age, meaning no single dose protocol fits all patients.
- Any HCG protocol for fertility or TRT support should be monitored with serial hormone labs and, for fertility goals, semen analysis to assess actual response.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr Gary Bellman | SoCalUrology · TikTok creator
10.2K views on this video
Replying to @faizal #hcg #hcglevels #hcgtherapy #trt #malefertility
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dr Gary Bellman | SoCalUrology, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.